Ethic Inc. Has $1.25 Million Stake in STERIS plc (NYSE:STE)

Ethic Inc. increased its stake in STERIS plc (NYSE:STE) by 5.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,087 shares of the medical equipment provider’s stock after acquiring an additional 297 shares during the quarter. Ethic Inc.’s holdings in STERIS were worth $1,251,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Avalon Trust Co bought a new stake in STERIS in the fourth quarter valued at $30,000. Human Investing LLC acquired a new stake in shares of STERIS in the 4th quarter valued at about $31,000. Anfield Capital Management LLC increased its position in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 91 shares in the last quarter. Manchester Capital Management LLC increased its position in STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares in the last quarter. Finally, Brown Brothers Harriman & Co. raised its stake in STERIS by 66.7% during the 4th quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 88 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Performance

Shares of STERIS stock opened at $231.15 on Wednesday. STERIS plc has a 52 week low of $200.98 and a 52 week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The business has a 50 day moving average price of $223.50 and a 200-day moving average price of $218.86. The company has a market cap of $22.71 billion, a PE ratio of 49.08 and a beta of 0.96.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be issued a dividend of $0.57 per share. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 annualized dividend and a yield of 0.99%. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

Analyst Ratings Changes

STE has been the subject of a number of research reports. Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Finally, Stephens raised shares of STERIS to a “strong-buy” rating in a research note on Thursday, May 1st. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.